Lahr Maarten M H, Vroomen Patrick C A J, Luijckx Gert-Jan, van der Zee Durk-Jouke, de Vos Ronald, Buskens Erik
Department of Neurology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Int J Stroke. 2014 Oct;9 Suppl A100:31-5. doi: 10.1111/ijs.12236. Epub 2013 Dec 23.
Treatment rates with intravenous tissue plasminogen activator vary by region, which can be partially explained by organizational models of stroke care. A recent study demonstrated that prehospital factors determine a higher thrombolysis rate in a centralized vs. decentralized model in the north of the Netherlands.
To investigate prehospital factors that may explain variation in thrombolytic therapy between a centralized and a decentralized model.
A consecutive case observational study was conducted in the north of the Netherlands comparing patients arriving within 4·5 h in a centralized vs. decentralized stroke care model. Factors investigated were transportation mode, prehospital diagnostic accuracy, and preferential referral of thrombolysis candidates. Potential confounders were adjusted using logistic regression analysis.
A total of 172 and 299 arriving within 4·5 h were enrolled in centralized and decentralized settings, respectively. The rate of transportation by emergency medical services was greater in the centralized model (adjusted odds ratio 3·11; 95% confidence interval, 1·59-6·06). Also, more misdiagnoses of stroke occurred in the central model (P = 0·05). In postal code areas with and without potential preferential referral of thrombolysis candidates due to overlapping catchment areas, the odds of hospital arrival within 4·5 h in the central vs. decentral model were 2·15 (95% confidence interval, 1·39-3·32) and 1·44 (95% confidence interval, 1·04-2·00), respectively.
These results suggest that the larger proportion of patients arriving within 4·5 h in the centralized model might be related to a lower threshold to use emergency services to transport stroke patients and partly to preferential referral of thrombolysis candidates.
静脉注射组织型纤溶酶原激活剂的治疗率因地区而异,这在一定程度上可以通过卒中护理的组织模式来解释。最近一项研究表明,在荷兰北部,与分散模式相比,集中模式下的院前因素决定了更高的溶栓率。
研究可能解释集中模式和分散模式之间溶栓治疗差异的院前因素。
在荷兰北部进行了一项连续病例观察研究,比较在集中式与分散式卒中护理模式下4.5小时内到达的患者。研究的因素包括运输方式、院前诊断准确性以及溶栓候选者的优先转诊。使用逻辑回归分析对潜在混杂因素进行调整。
分别有172例和299例在4.5小时内到达的患者纳入集中式和分散式治疗组。集中式模式下通过紧急医疗服务进行运输的比例更高(调整后的优势比为3.11;95%置信区间为1.59 - 6.06)。此外,集中式模式下卒中误诊情况更多(P = 0.05)。在因集水区重叠而有或没有潜在优先转诊溶栓候选者的邮政编码区域,集中式与分散式模式下4.5小时内到达医院的优势比分别为2.15(95%置信区间为1.39 - 3.32)和1.44(95%置信区间为1.04 - 2.00)。
这些结果表明,集中式模式下4.5小时内到达的患者比例较高,可能与使用紧急服务转运卒中患者的较低阈值以及部分与溶栓候选者的优先转诊有关。